F2RL3 Polyclonal antibody
F2RL3 Polyclonal Antibody for FC, IHC, WB, ELISA
Host / Isotype
Rabbit / IgG
WB, IHC, FC, ELISA
Cat no : 25306-1-AP
|Positive WB detected in||mouse lung tissue, mouse pancreas tissue|
|Positive IHC detected in||mouse lung tissue|
Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0
|Positive FC detected in||HeLa cells|
|Western Blot (WB)||WB : 1:500-1:2000|
|Immunohistochemistry (IHC)||IHC : 1:20-1:200|
|Sample-dependent, check data in validation data gallery|
The immunogen of 25306-1-AP is F2RL3 Fusion Protein expressed in E. coli.
|Tested Reactivity||human, mouse|
|Cited Reactivity||human, mouse|
|Host / Isotype||Rabbit / IgG|
|Immunogen||F2RL3 fusion protein Ag20801|
|Full Name||coagulation factor II (thrombin) receptor-like 3|
|Calculated molecular weight||385 aa, 41 kDa|
|Observed molecular weight||41 kDa|
|GenBank accession number||BC074782|
|Gene ID (NCBI)||9002|
|Purification Method||Antigen affinity purification|
|Storage Buffer||PBS with 0.02% sodium azide and 50% glycerol pH 7.3.|
|Storage Conditions||Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA.|
Coagulation factor II receptor-like 3 (F2RL3) encodes a member of the protease-activated receptor subfamily, also known as protease-activated receptor 4 (PAR4), which takes partin platelet activation, intimal hyperplasia and inflammation (PMID:34284820). An absence of PAR4 in mouse models results in impaired hemostasis and a protection against pulmonary embolism, and a small number of missense coding variants in F2RL3 that alter platelet aggregation and function have been described(PMID:35012325). The calculated molecular weight and observed molecular weight of F2RL3 are both 41 kDa.
|Product Specific Protocols|
|WB protocol for F2RL3 antibody 25306-1-AP||Download protocol|
|IHC protocol for F2RL3 antibody 25306-1-AP||Download protocol|
|FC protocol for F2RL3 antibody 25306-1-AP||Download protocol|
|Click here to view our Standard Protocols|
Tumor Suppressor Par-4 Regulates Complement Factor C3 and Obesity.
Antagonism of Protease-Activated Receptor 4 Protects Against Traumatic Brain Injury by Suppressing Neuroinflammation via Inhibition of Tab2/NF-κB Signaling.
Oxid Med Cell Longev
Combination of Colchicine and Ticagrelor Inhibits Carrageenan-Induced Thrombi in Mice.